Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

Possibly Marketed Outside US

7

Investigational

1

US Previously Marketed

1

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

1

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

Unknown

2

1921

1

1960

1

1981

1

2006

1

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Erectile dysfunction

1

Intermittent claudication

1

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Inactive ingredient

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Structurally Diverse

6

Chemical

1

Mixture

1

Polymer

1

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

DSLD

9

FDA UNII

9

DAILYMED

7

EVMPD

6

CAS

5

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

ALIMENTARY TRACT AND METABOLISM

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

INTESTINAL ADSORBENTS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Other intestinal adsorbents

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

8

Salts, Hydrates, Esters, etc.

1

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "Dietary Supplement Label Database|Fiber" in comments (approximate match)

Showing 1 - 9 of 9 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

ALFADEX

Z1LH97KTRM

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 1981

Class (Stereo):

CHEMICAL (ABSOLUTE)

Conditions:

Intermittent claudication

Erectile dysfunction

Alfadex also known as α-cyclodextrin, is used as an inactive ingredient in order to improve the water solubility of the different drugs, e.g. edex: is a sterile, pyrogen-free powder containing alprostadil in an alfadex inclusion complex. After intrav...

enous infusion of radiolabeled α-cyclodextrin to healthy volunteers, the radiolabeled components were rapidly eliminated within 24-hours, urine accounting for 81-83% of radioactivity and feces for 0.1%. There was no evidence of significant accumulation of radiolabeled α-cyclodextrin in the body even after 7 days of repeated intravenous injection. After intracavernous administration in monkeys, radiolabeled α¬ cyclodextrin was rapidly distributed from the injection site with less than 0.1% of the dose remaining in the penis 1 hour after administration. There was no evidence of tissue retention of radiolabeled α-cyclodextrin in monkeys.

POLYDEXTROSE

VH2XOU12IE

Export Data

Status:

Possibly Marketed Outside US

First approved in 1960

Class:

POLYMER

BETA VULGARIS FIBER

3CK0EOO6FA

Status:

Investigational

Class:

STRUCTURALLY DIVERSE

PEA FIBER

KF5Q0VDK1N

Status:

Possibly Marketed Outside US

First approved in 2023

Class:

STRUCTURALLY DIVERSE

LOCUST BEAN GUM

V4716MY704

Status:

Possibly Marketed Outside US

First approved in 2013

Class:

STRUCTURALLY DIVERSE

GALACTOARABINAN

SL4SX1O487

Status:

Possibly Marketed Outside US

First approved in 2009

Class:

STRUCTURALLY DIVERSE

OAT BRAN

KQX236OK4U

Status:

Possibly Marketed Outside US

First approved in 2006

Class:

STRUCTURALLY DIVERSE

CORN BRAN

1L922R9NG2

Status:

Possibly Marketed Outside US

Class:

STRUCTURALLY DIVERSE

Pectin

89NA02M4RX

Status:

US Previously Marketed

First marketed in 1921

Class:

MIXTURE

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1